US 11472772
S1P3 antagonists
granted A61PA61P29/00
Quick answer
US patent 11472772 (S1P3 antagonists) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P29/00